TABLE 3.
Age Range (y) | AD | IgE-FA | Asthma | AR | EoE | |||||
---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | n | % | |
0–<3 | 19 543 | 8.9 | 6336 | 2.9 | 31 141 | 14.3 | 22 753 | 10.4 | 94 | 0.04 |
0–<5 | 21 051 | 9.6 | 7412 | 3.4 | 38 312 | 17.5 | 32 982 | 15.1 | 139 | 0.06 |
0–<11 | 22 264 | 10.2 | 8500 | 3.9 | 43 219 | 19.8 | 42 154 | 19.3 | 210 | 0.10 |
0–<14 | 22 415 | 10.3 | 8665 | 4.0 | 43 778 | 20.0 | 42 930 | 19.6 | 229 | 0.10 |
0–18 | 22 437 | 10.3 | 8706 | 4.0 | 43 853 | 20.1 | 43 034 | 19.7 | 234 | 0.11 |
All reported percentages indicate the percentage of total subjects in the full cohort (n = 218 485) with the stated allergic disease. AD, atopic dermatitis; AR, allergic rhinitis; EoE, eosinophilic esophagitis; IgE-FA, immunoglobulin E–mediated food allergy.